Paeonol inhibits prostate cancer progression via the miR-145-5p/GOLM1 axis
American Journal of Cancer Research · 2026 · 16 (5) · 1776-1790
DOI: 10.62347/ynve5413 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Yingxin Zhang. Beteiligte Einrichtung: College of Life and Environmental Sciences, Minzu University of China Beijing 100081, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
e-Century Publishing Corporation, Madison, Wisconsin, USA publishes 17 medical journals, with 13 of them officially indexed in PubMed and archived in PubMed Central, 11 of them are indexed in SCI Web of Science (2 in SCIE with Impact Factors and 8 in ESCI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life and Environmental Sciences, Minzu University of China Beijing 100081, China.
Zitieren
APA
Zhang, Y. (2026). Paeonol inhibits prostate cancer progression via the miR-145-5p/GOLM1 axis. American Journal of Cancer Research, 16(5), 1776-1790. https://doi.org/10.62347/ynve5413
Vancouver
Zhang Y. Paeonol inhibits prostate cancer progression via the miR-145-5p/GOLM1 axis. American Journal of Cancer Research. 2026;16(5):1776-1790. doi:10.62347/ynve5413
BibTeX
@article{Zhang2026,
author = {Zhang, Yingxin},
title = {Paeonol inhibits prostate cancer progression via the miR-145-5p/GOLM1 axis},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {5},
pages = {1776--1790},
doi = {10.62347/ynve5413}
}
EUVIMED